Pixyl

La Tronche, France  All France companies → Founded 2015
Imaging AI Specialist Specialty-Focused AI
Acquired (by Gleamer on March 3, 2025) — $4.18M (Note: Some sources indicate $3.19M over 2 rounds or €2.2 million in a single round)

Products

Pixyl.Neuro
Pixyl
Clinical Decision Support & Reference
Pixyl.Neuro is an FDA-cleared AI tool that detects and monitors brain anomalies and changes on MR images for neuroinflammatory and neurodegenerative disorders.

See all 1 product →

About Pixyl

Pixyl is a French healthcare AI company that specializes in neuroimaging analysis, aiming to improve patient care by providing advanced AI technology to radiologists and clinicians. The company’s flagship product, Pixyl.Neuro, is an AI-powered software designed for the automated analysis of brain MRI images. This tool assists in the rapid detection, early diagnosis, and objective monitoring of various neurological disorders, including neuroinflammatory diseases like multiple sclerosis, migraines, and epilepsy, as well as neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and Huntington’s.

Pixyl.Neuro integrates seamlessly into routine radiology workflows, offering features such as automatic detection, quantification, and characterization of lesions, as well as longitudinal analysis to track disease evolution. The software quantifies brain region volumes and compares them to normative data to identify abnormal atrophy, aiding in differential diagnosis. It delivers results within minutes using minimal MRI protocols, thereby enhancing detection rates, accelerating MRI reading times, and providing quantitative information for faster and more confident reporting. Pixyl.Neuro has received CE-mark class IIa certification in the European Union and FDA 510(k) clearance in the United States, underscoring its adherence to high-quality medical device standards.

Focus Areas

AI-powered MRI analysis neuroimaging neurological disorders multiple sclerosis dementia stroke traumatic brain injury precision medicine diagnostic support predictive imaging solutions

Business Intelligence

Key InvestorsElaia, Holnest, Bpifrance, Crédit Agricole, IT-Translation, Davycrest Nominees, Medevice Capital
PartnershipsBrainomix, Blackford Analysis, GE HealthCare (AI.Dream consortium), French Observatory for Multiple Sclerosis (OFSEP), Incepto Medical, UC Davis
AcquisitionsAcquired by Gleamer (March 12, 2025)
TechnologyDeep Learning, generative AI technology, cloud-native (Software-as-a-Service - SaaS)
FDA Clearances1 (Pixyl.Neuro) cleared products (estimated)

What Physicians Need to Know

AI-Powered MRI Analysis for Neurological Disorders
Pixyl specializes in AI-powered MRI analysis, particularly for neuroinflammatory and neurodegenerative disorders such as Multiple Sclerosis, dementia, stroke, and traumatic brain injury. Their flagship product, Pixyl.Neuro, automatically analyzes brain MRI images to support rapid detection, early diagnosis, and objective monitoring of these conditions.
Enhanced Detection and Accelerated Reading Time
Pixyl.Neuro has demonstrated enhanced detection rates for neurological disease activity, with studies showing up to a 28% improvement. The software is designed to accelerate MRI reading time, providing quick analysis in less than 5 minutes.
Quantitative Biomarkers and Longitudinal Follow-up
The platform provides quantitative measures of lesion volume, brain atrophy, and white matter hyperintensities. It also offers longitudinal analysis, tracking changes over time to monitor disease evolution and treatment response, and comparing patient values to normative data.
Regulatory Clearances and Real-World Validation
Pixyl.Neuro has received FDA 510(k) clearance in the U.S. and CE-mark class IIa certification in the European Union, ensuring high quality in medical device development. The AI-powered technology has been rigorously tested in real-world conditions and clinical studies.
Precision Medicine and Diagnostic Support
Pixyl aims to make precision medicine the standard of care by providing clinicians with access to previously unavailable, clinically relevant information to reinforce radiology workflows and support differential diagnosis.
Physician Tip

For physicians, Pixyl.Neuro can be a game-changer in neurological practice. It offers rapid, objective, and quantitative analysis of brain MRIs, which is crucial for early diagnosis, monitoring disease progression, and tailoring treatment for conditions like Multiple Sclerosis and Alzheimer's disease. The software integrates seamlessly into existing radiology workflows, reducing reading time and providing peace of mind, especially for stable MS MRI exams. The ability to track subtle changes and compare against normative data can significantly enhance diagnostic confidence and patient management.

Pixyl's solutions are designed to integrate seamlessly into the radiology workflow. They are available directly from Pixyl and through select distributors. Pixyl has also formed partnerships with leading healthcare organizations and companies like Gleamer and Brainomix to expand its offerings and distribution.

Products by Pixyl

1 product in the directory

Pixyl.Neuro
Pixyl
Clinical Decision Support & Reference
Pixyl.Neuro is an FDA-cleared AI tool that detects and monitors brain anomalies and changes on MR images for neuroinflammatory and neurodegenerative disorders.

What the Web Says

Pixyl (pixylmedical.com) is a company specializing in AI-powered brain MRI analysis software, Pixyl.Neuro, which has received FDA clearance and CE-mark class IIa certification in the EU. The software aims to improve the detection, diagnosis, and monitoring of neurodegenerative and neuroinflammatory disorders by accelerating MRI reading time and quantifying brain region volumes. While there are positive reviews from healthcare professionals regarding its efficacy and impact on workflow, there is limited information available on employer reviews for Pixyl Medical specifically. It's important to distinguish Pixyl Medical from other companies with similar names like Pixyle AI (fashion data enrichment), Pixly (marketing agency/construction photo collaboration), and Pixyls (sticker art).

Overall: Positive

Strengths

  • Enhanced detection rates for neurological disease activity (up to 28%).
  • Accelerates MRI reading time (results in minutes).
  • Supports early diagnosis and objective monitoring of neurological disorders.
  • Quantifies brain region volumes to identify abnormal atrophy.
  • Leverages generative AI technology for robust performance.
  • Positive feedback from neuroradiology directors and users on quality and support.

Limitations

  • Limited public product reviews outside of official announcements and expert testimonials.
  • No specific employer reviews found for Pixyl Medical on Glassdoor or Indeed.
  • Potential for confusion with similarly named companies offering different products/services.
  • No information on pricing or implementation challenges from user reviews.
  • No detailed customer support feedback available from Capterra for Pixyl Software (digital signage, not medical).

Based on reviews from: NeurologyLive, Applied Radiology, AuntMinnie, Medical Device Network, G2, Capterra, Reddit

Last updated: 2026-06-22

Videos

News, demos, and interviews about Pixyl.

Loading videos...

Videos load interactively. If none appear, search YouTube for Pixyl →

View all on YouTube

Press & Coverage

Imaging Technology News
Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro
Pixyl announced FDA 510(k) clearance for Pixyl.Neuro, its AI software for brain MRI analysis, which has shown enhanced detection rates up to 28%. The software supports rapid detection, early diagnosis, and objective monitoring of neurological disorders.
2023-12
NeurologyLive
FDA Clears AI-Powered Brain MRI Software Pixyl.Neuro
The FDA granted 510(k) clearance to Pixyl.Neuro, an AI-generated medical technology designed to detect anomalies and changes in brain MR images for neuroinflammatory and neurodegenerative disorders. The software has also received CE-mark class IIa certification in the European Union.
2023-11
AuntMinnie
Pixyl receives FDA clearance for AI brain MRI software
Pixyl's AI software for brain MRI analysis, Pixyl.Neuro, has been cleared by the U.S. Food and Drug Administration (FDA). The company states the software boosts detection rates by up to 28% and is used in over 12 countries.
2023-11
Radiology Business
FDA clears AI-powered brain MRI software from French firm Pixyl
The FDA has cleared Pixyl's AI-powered software for analyzing brain MRIs, Pixyl.Neuro, which aims to improve detection rates and reduce radiologists' read times for neurological disorders. The software quantifies brain region volumes and compares them against healthy patient data.
2023-11
Applied Radiology
Pixyl Nets FDA Clearance for AI-Powered Brain MR Software
Pixyl has received FDA 510(k) clearance for its Pixyl.Neuro AI software, which automatically analyzes brain MR images to support the detection, diagnosis, and monitoring of neurological disorders. The company emphasizes its adherence to the latest FDA AI guidelines.
2023-11
Tracxn (citing GlobeNewswire)
Blackford and Pixyl Partner to Aid Detection and Monitoring of Neurological Diseases
Blackford and Pixyl announced a partnership to aid in the detection and monitoring of neurological diseases. This collaboration aims to expand the reach and distribution of Pixyl's AI-powered solutions.
2024-03
Tracxn (citing DOTmed)
Gleamer expands AI imaging portfolio with acquisitions of Pixyl and Caerus Medical
Gleamer acquired Pixyl and Caerus Medical, expanding its AI imaging portfolio. This acquisition signifies a consolidation in the medical imaging AI market.
2025-03
Actu IA
Pixyl raises u20ac2.2 million to market its neurological pathology detection solution
Pixyl announced a u20ac2.2 million fundraising round from Elaia, Bpifrance, and Holnest to accelerate the marketing of its flagship software suite and expand into the US market. The funding will also support the European launch of Pixyl.Neurou2122.
2021-04

Frequently Asked Questions

Pixyl's AI-powered MRI analysis is designed to assist in the diagnosis and monitoring of a range of neurological disorders, including multiple sclerosis, dementia, stroke, and traumatic brain injury. The technology provides quantitative insights from neuroimaging data to support clinicians in their assessment of these complex conditions.
Pixyl's solutions are built for seamless integration into existing clinical workflows, including Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems. This ensures that the AI-powered analysis can be easily incorporated into a physician's current diagnostic process and patient management.
Pixyl's software adheres to stringent regulatory clearances and compliance standards for medical device use, including CE marking under the Medical Device Regulation (MDR) in Europe and FDA clearance in the United States. This ensures the safety, efficacy, and quality of their AI-powered neuroimaging analysis tools.
Yes, Pixyl's AI-powered platform aims to provide predictive imaging solutions that can offer insights into disease progression and potential treatment response for various neurological conditions. By analyzing subtle changes in neuroimaging data over time, the technology supports more personalized and precise patient management.
While specific pricing models can vary based on the scale of implementation and specific modules required, Pixyl generally offers subscription-based models. These typically include comprehensive technical support, regular software updates, and dedicated customer service to ensure optimal performance and user satisfaction.
Pixyl prioritizes the data privacy and security of patient MRI scans by implementing robust encryption protocols and adhering to international data protection regulations such as GDPR and HIPAA. Their systems are designed to process anonymized or de-identified data where appropriate, ensuring patient confidentiality.
Pixyl has established a strong track record in the field of AI neuroimaging, with its technology being adopted by numerous hospitals and research institutions globally. The company continues to expand its market presence through strategic partnerships and ongoing innovation in neurological diagnostic support.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.